| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c9446a65422eaca792040fe2b817fb5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
| filingDate |
1983-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_216191d5352914582e5715967a1bf580 |
| publicationDate |
1984-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2124901-A |
| titleOfInvention |
Enhancer of anti-tumor effect |
| abstract |
1- beta -D-arabinofuranosyladenine derivatives represented by the formula (I): <IMAGE> wherein R<1> designates hydrogen or an acyl group and R<2> designates a hydroxyl group, a phosphoric acid residue or an alkyl-or alkenylphosphate residue; or pharmaceutically acceptable salts thereof are disclosed as being effective for enhancing anti-tumor effect afforded by irradiation to or administration of an anti-tumor pharmaceutical to tumor- bearing animals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7148207-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1306929-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547776-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03053418-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100884685-B1 |
| priorityDate |
1982-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |